These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19300145)

  • 21. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
    Snir M; Weinberger D; Bourla D; Kristal-Shalit O; Dotan G; Axer-Siegel R
    Am J Ophthalmol; 2003 Jul; 136(1):99-105. PubMed ID: 12834676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections.
    Sharma P; Czyz CN; Wulc AE
    Aesthet Surg J; 2011 Nov; 31(8):966-71. PubMed ID: 22001341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections.
    Saeliw P; Preechawai P; Aui-aree N
    J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.
    Poonyathalang A; Preechawat P; Jamnansiri U
    Jpn J Ophthalmol; 2005; 49(4):327-8. PubMed ID: 16075337
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.
    Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S;
    J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method.
    Weiss RA; Lavin PT
    Ophthalmic Plast Reconstr Surg; 2009; 25(3):173-7. PubMed ID: 19454924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.
    Fang XB; Xie MS; Song ZB; Zhong ZG; Wang Y; Ou ZL; Dang C; Li L; Zhang WX
    Neurol Sci; 2020 Mar; 41(3):645-652. PubMed ID: 31745757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection.
    Elibol O; Ozkan B; Hekimhan PK; Cağlar Y
    Ophthalmic Plast Reconstr Surg; 2007; 23(2):130-3. PubMed ID: 17413628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A injection in the treatment of hemifacial spasm.
    Chen RS; Lu CS; Tsai CH
    Acta Neurol Scand; 1996 Sep; 94(3):207-11. PubMed ID: 8899054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of botulinum toxin type a after topical anesthesia.
    Sami MS; Soparkar CN; Patrinely JR; Hollier LM; Hollier LH
    Ophthalmic Plast Reconstr Surg; 2006; 22(6):448-52. PubMed ID: 17117100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin injection and tear production.
    Alsuhaibani AH; Eid SA
    Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time.
    Drummond GT; Hinz BJ
    Can J Ophthalmol; 2001 Dec; 36(7):398-403. PubMed ID: 11794389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline.
    Kwiat DM; Bersani TA; Bersani A
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):186-9. PubMed ID: 15167724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and side-effects of the botulinum toxin A treatment in patients with focal dystonia].
    Likhachev SA; Rushkevich IuN; Chernukha TN; Veevnik EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):27-31. PubMed ID: 19365387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
    Jochim A; Meindl T; Huber C; Mantel T; Zwirner S; Castrop F; Haslinger B
    J Neurol; 2020 Jan; 267(1):267-275. PubMed ID: 31630241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection.
    Casse G; Adenis JP; Sauvage JP; Robert PY
    Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diplopia following subcutaneous injections of botulinum A toxin for facial spasms.
    Wutthiphan S; Kowal L; O'Day J; Jones S; Price J
    J Pediatr Ophthalmol Strabismus; 1997; 34(4):229-34. PubMed ID: 9253737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.